Investing.com - Marchex (NASDAQ: MCHX) reported third quarter EPS of $-0.010, in line with the analyst estimate of $-0.010. Revenue for the quarter came in at $12.6M versus the consensus estimate of $12.59M.
Guidance
Marchex sees Q4 2024 revenue of $12.000M versus the analyst consensus of $12.350M.
Marchex's stock price closed at $1.84. It is down -2.650% in the last 3 months and up 38.350% in the last 12 months.
Marchex saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Marchex's stock price’s past reactions to earnings here.
According to InvestingPro, Marchex's Financial Health score is "fair performance".
Check out Marchex's recent earnings performance, and Marchex's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar